| Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process J Jaiswal, SK Gupta, J Kreuter Journal of Controlled Release 96 (1), 169-178, 2004 | 176 | 2004 |
| Piperine in food: interference in the pharmacokinetics of phenytoin T Velpandian, R Jasuja, RK Bhardwaj, J Jaiswal, SK Gupta European journal of drug metabolism and pharmacokinetics 26, 241-247, 2001 | 141 | 2001 |
| Pharmacokinetic/pharmacodynamic modeling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors KO Hicks, BG Siim, JK Jaiswal, FB Pruijn, AM Fraser, R Patel, A Hogg, ... Clinical Cancer Research 16 (20), 4946-4957, 2010 | 138 | 2010 |
| Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases R Bisht, A Mandal, JK Jaiswal, ID Rupenthal Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 10 (2 …, 2018 | 122 | 2018 |
| Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples T Velpandian, J Jaiswal, RK Bhardwaj, SK Gupta Journal of Chromatography B: Biomedical Sciences and Applications 738 (2 …, 2000 | 116 | 2000 |
| Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application SK Gupta, P Bansal, RK Bhardwaj, J Jaiswal, T Velpandian Skin Pharmacology and Physiology 15 (2), 105-111, 2002 | 107 | 2002 |
| Intravitreal pharmacokinetics of plain and liposome-entrapped fluconazole in rabbit eyes SK Gupta, T Velpandian, N Dhingra, J Jaiswal Journal of ocular pharmacology and therapeutics 16 (6), 511-518, 2000 | 81 | 2000 |
| Transdermal delivery of naloxone: ex vivo permeation studies J Jaiswal, R Poduri, R Panchagnula International journal of pharmaceutics 179 (1), 129-134, 1999 | 54 | 1999 |
| The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice TL Merry, AES Brooks, SW Masson, SE Adams, JK Jaiswal, ... International Journal of Obesity 44 (1), 245-253, 2020 | 43 | 2020 |
| Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno [2, 3-b] pyridine derivative J Reynisson, JK Jaiswal, D Barker, SAN D’mello, WA Denny, BC Baguley, ... Cancer Cell International 16, 1-9, 2016 | 42 | 2016 |
| Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye R Bisht, JK Jaiswal, YS Chen, J Jin, ID Rupenthal Expert opinion on drug delivery 13 (7), 953-962, 2016 | 37 | 2016 |
| An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroids X Mao, S McManaway, JK Jaiswal, PB Patel, WR Wilson, KO Hicks, ... PLoS computational biology 14 (10), e1006469, 2018 | 32 | 2018 |
| Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects CR Hong, BD Dickson, JK Jaiswal, FB Pruijn, FW Hunter, MP Hay, ... Biochemical pharmacology 156, 265-280, 2018 | 31 | 2018 |
| Efficacy of fluconazole and liposome entrapped fluconazole for C. albicans induced experimental mycotic endophthalmitis in rabbit eyes SK Gupta, N Dhingra, T Velpandian, J Jaiswal Acta Ophthalmologica Scandinavica 78 (4), 448-450, 2000 | 30 | 2000 |
| Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye R Bisht, JK Jaiswal, ID Rupenthal Medical Hypotheses 103, 5-9, 2017 | 26 | 2017 |
| Preparation and evaluation of PLGA nanoparticle-loaded biodegradable light-responsive injectable implants as a promising platform for intravitreal drug delivery R Bisht, JK Jaiswal, VF Oliver, C Eurtivong, J Reynisson, ID Rupenthal Journal of Drug Delivery Science and Technology 40, 142-156, 2017 | 25 | 2017 |
| The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs FW Hunter, JK Jaiswal, DG Hurley, HDS Liyanage, SP McManaway, Y Gu, ... Biochemical Pharmacology 89 (2), 224-235, 2014 | 24 | 2014 |
| Reductive metabolism influences the toxicity and pharmacokinetics of the hypoxia-targeted benzotriazine di-oxide anticancer agent SN30000 in mice Y Gu, TTA Chang, J Wang, JK Jaiswal, D Edwards, NJ Downes, ... Frontiers in pharmacology 8, 531, 2017 | 20 | 2017 |
| Diarylthiophenes as inhibitors of the pore-forming protein perforin CK Miller, KM Huttunen, WA Denny, JK Jaiswal, A Ciccone, KA Browne, ... Bioorganic & medicinal chemistry letters 26 (2), 355-360, 2016 | 20 | 2016 |
| Print CG, Wilson WR, Pruijn FB (2014) The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxiatargeting prodrugs FW Hunter, JK Jaiswal, DG Hurley, HD Liyanage, SP McManaway, Y Gu, ... Biochem Pharmacol 89, 224-235, 0 | 16 | |
Dr.Velpandian ThirumurthyProfessor, Ocular Pharmacology & Pharmacy Div, Dr.RPCentre, AIIMS, New DelhiVerified email at aiims.ac.in
